Linopirdine: Difference between revisions
Appearance
Content deleted Content added
remove content added by sock of blocked user Nuklear |
m Bot: Deprecating Template:Cite pmid and some minor fixations |
||
Line 54: | Line 54: | ||
}} |
}} |
||
'''Linopirdine''' is a putative cognition-enhancing drug with a novel mechanism of action. Linopirdine blocks the KCNQ2\3 heteromer M current with an IC50 of 2.4nM<ref name="pmid9694925">{{Cite |
'''Linopirdine''' is a putative cognition-enhancing drug with a novel mechanism of action. Linopirdine blocks the KCNQ2\3 heteromer M current with an IC50 of 2.4nM<ref name="pmid9694925">{{Cite journal |
||
| last1 = Schnee | first1 = M. E. |
|||
| last2 = Brown | first2 = B. S. |
|||
| title = Selectivity of linopirdine (DuP 996), a neurotransmitter release enhancer, in blocking voltage-dependent and calcium-activated potassium currents in hippocampal neurons |
|||
| journal = The Journal of pharmacology and experimental therapeutics |
|||
| volume = 286 |
|||
| issue = 2 |
|||
| pages = 709–717 |
|||
| year = 1998 |
|||
| pmid = 9694925 |
|||
}}</ref> disinhibiting acetylcholine release, and increasing hippocampal CA3-schaffer collateral mediated glutamate release onto CA1 pyramidal neurons.<ref name="pmid22674722">{{Cite journal |
|||
| last1 = Sun | first1 = J. |
|||
| last2 = Kapur | first2 = J. |
|||
| doi = 10.1113/jphysiol.2012.235820 |
|||
| title = M-type potassium channels modulate Schaffer collateral-CA1 glutamatergic synaptic transmission |
|||
| journal = The Journal of Physiology |
|||
| volume = 590 |
|||
| issue = 16 |
|||
| pages = 3953–3964 |
|||
| year = 2012 |
|||
| pmid = 22674722 |
|||
| pmc =3476642 |
|||
}}</ref> In a murine model linopirdine is able to nearly completely reverse the senescence-related decline in cortical c-FOS, an effect which is blocked by atropine and MK-801, suggesting Linopirdine can compensate for the age related decline in acetylcholine release.<ref name="pmid11378256">{{Cite journal |
|||
| last1 = Dent | first1 = G. W. |
|||
| last2 = Rule | first2 = B. L. |
|||
| last3 = Zhan | first3 = Y. |
|||
| last4 = Grzanna | first4 = R. |
|||
| title = The acetylcholine release enhancer linopirdine induces Fos in neocortex of aged rats |
|||
| journal = Neurobiology of aging |
|||
| volume = 22 |
|||
| issue = 3 |
|||
| pages = 485–494 |
|||
| year = 2001 |
|||
| pmid = 11378256 | doi=10.1016/s0197-4580(00)00252-9 |
|||
}}</ref> Linopirdine also blocks homomeric KCNQ1 and KCNQ4 voltage gated potassium channels which contribute to vascular tone with substantially less selectivity than KCNQ2/3.<ref name="pmid9694925">{{Cite journal |
|||
| last1 = Schnee | first1 = M. E. |
|||
| last2 = Brown | first2 = B. S. |
|||
| title = Selectivity of linopirdine (DuP 996), a neurotransmitter release enhancer, in blocking voltage-dependent and calcium-activated potassium currents in hippocampal neurons |
|||
| journal = The Journal of pharmacology and experimental therapeutics |
|||
| volume = 286 |
|||
| issue = 2 |
|||
| pages = 709–717 |
|||
| year = 1998 |
|||
| pmid = 9694925 |
|||
}}</ref> |
|||
==References== |
==References== |
Revision as of 22:24, 27 August 2015
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C26H21N3O |
Molar mass | 391.465 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Linopirdine is a putative cognition-enhancing drug with a novel mechanism of action. Linopirdine blocks the KCNQ2\3 heteromer M current with an IC50 of 2.4nM[1] disinhibiting acetylcholine release, and increasing hippocampal CA3-schaffer collateral mediated glutamate release onto CA1 pyramidal neurons.[2] In a murine model linopirdine is able to nearly completely reverse the senescence-related decline in cortical c-FOS, an effect which is blocked by atropine and MK-801, suggesting Linopirdine can compensate for the age related decline in acetylcholine release.[3] Linopirdine also blocks homomeric KCNQ1 and KCNQ4 voltage gated potassium channels which contribute to vascular tone with substantially less selectivity than KCNQ2/3.[1]
References
- ^ a b Schnee, M. E.; Brown, B. S. (1998). "Selectivity of linopirdine (DuP 996), a neurotransmitter release enhancer, in blocking voltage-dependent and calcium-activated potassium currents in hippocampal neurons". The Journal of pharmacology and experimental therapeutics. 286 (2): 709–717. PMID 9694925.
- ^ Sun, J.; Kapur, J. (2012). "M-type potassium channels modulate Schaffer collateral-CA1 glutamatergic synaptic transmission". The Journal of Physiology. 590 (16): 3953–3964. doi:10.1113/jphysiol.2012.235820. PMC 3476642. PMID 22674722.
- ^ Dent, G. W.; Rule, B. L.; Zhan, Y.; Grzanna, R. (2001). "The acetylcholine release enhancer linopirdine induces Fos in neocortex of aged rats". Neurobiology of aging. 22 (3): 485–494. doi:10.1016/s0197-4580(00)00252-9. PMID 11378256.